Inventor
CHU HANG
US18 patents
⚠️ This page may combine multiple inventors who share the name “CHU HANG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GILEAD SCIENCES INC
16 patentsUS11084832B2Aug 10, 2021
Bridged tricyclic carbamoylpyridone compounds and their pharmaceutical use
GILEAD SCIENCES INC25 citations93
US10703733B2Jul 7, 2020
MCL-1 inhibitors
GILEAD SCIENCES INC12 citations93
US11897892B2Feb 13, 2024
Substituted pyridotriazine compounds and uses thereof
GILEAD SCIENCES INC6 citations85
US10988451B2Apr 27, 2021
MCL-1 inhibitors
GILEAD SCIENCES INC10 citations85
US12024528B2Jul 2, 2024
Bridged tricyclic carbamoylpyridone compounds and uses thereof
GILEAD SCIENCES INC6 citations84
US11613546B2Mar 28, 2023
Substituted pyridotriazine compounds and uses thereof
GILEAD SCIENCES INC9 citations84
US11548902B1Jan 10, 2023
Bridged tricyclic carbamoylpyridone compounds and their pharmaceutical use
GILEAD SCIENCES INC7 citations84
US12187734B2Jan 7, 2025
Substituted pyridotriazine compounds and uses thereof
GILEAD SCIENCES INC1 citations74
US11643400B2May 9, 2023
MCL-1 inhibitors
GILEAD SCIENCES INC4 citations74
US12054496B2Aug 6, 2024
Bridged tricyclic carbamoylpyridone compounds and uses thereof
GILEAD SCIENCES INC2 citations72
US11667652B2Jun 6, 2023
MCL1 inhibitors
GILEAD SCIENCES INC2 citations72
US12404262B2Sep 2, 2025
Therapeutic compounds for HIV virus infection
GILEAD SCIENCES INC1 citations63
US12227520B2Feb 18, 2025
Bridged tricyclic carbamoylpyridone compounds and their pharmaceutical use
GILEAD SCIENCES INC0 citations62
US12202842B2Jan 21, 2025
MCL1 inhibitors
GILEAD SCIENCES INC0 citations62
US12162844B2Dec 10, 2024
MCL-1 inhibitors
GILEAD SCIENCES INC0 citations62
US12421235B2Sep 23, 2025
Bridged tricyclic carbamoylpyridone compounds and uses thereof
GILEAD SCIENCES INC0 citations60